Erin Arthur
Family Medicine · Collbran, CONPI 1871753434
Payments from drug & device makers
Across 186 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$702
- AstraZeneca$398
- GSK$288
- Amgen$284
- Astellas Pharma US Inc$177
- Otsuka America Pharmaceutical, Inc.$161
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,324100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $702 |
| AstraZeneca | 23 | $398 |
| GSK | 15 | $288 |
| Amgen | 15 | $284 |
| Astellas Pharma US Inc | 9 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $161 |
| Lilly USA, LLC | 10 | $150 |
| Novo Nordisk | 8 | $139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $134 |
| Johnson & Johnson | 7 | $104 |
| Pfizer | 6 | $104 |
| Harmony Biosciences LLC | 4 | $82 |
| Boehringer Ingelheim | 3 | $73 |
| Edwards Lifesciences | 2 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Viatris Specialty LLC | 2 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $38 |
| Merck | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Eisai Inc. | 2 | $32 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Vertex | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,324 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $49,953 |
| OzempicSemaglutide | 44 | $43,036 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $16,425 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 33 | $15,394 |
| TrulicityDulaglutide | 15 | $15,028 |
| MounjaroTirzepatide | 11 | $11,976 |
| Spiriva RespimatTiotropium Bromide | 14 | $9,727 |
| LinzessLinaclotide | 12 | $6,342 |
| Gabapentin | 136 | $4,123 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $2,535 |
| Rosuvastatin Calcium | 99 | $2,394 |
| Duloxetine Hcl | 48 | $2,107 |
| Lisdexamfetamine Dimesylate | 11 | $2,022 |
| Levothyroxine Sodium | 196 | $2,016 |
| Famotidine | 40 | $1,774 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $104 | $49,95361 claims |
| Novo NordiskOzempic | $139 | $43,03644 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $288 | $31,82052 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $150 | $27,00426 claims |
| Boehringer IngelheimSpiriva Respimat | $73 | $9,72714 claims |
| AbbVieLinzess, Armour Thyroid | $702 | $7,20632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Collbran
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
- Astrid LampeyFraser$568K
- Kari UusinarkausWoodland Park$520K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.